Abstract: The present invention generally relates to the field of plant genetics and protein biochemistry. More specifically, the present invention relates to modified proteins having an increased number of essential amino acids. The invention provides proteins modified to have an increased number of essential amino acids, nucleic acid sequences encoding the enhanced proteins, and methods of designing, producing, and using the same. The invention also includes compositions, transformed host cells, transgenic plants and seeds containing the enhanced proteins, and methods for preparing and using the same.
Type:
Grant
Filed:
September 17, 2002
Date of Patent:
August 30, 2005
Assignee:
Monsanto Company
Inventors:
William D. Rapp, Jiexin Peng, Gautham Nadig, Tyamagondlu Venkatesh
Abstract: The present invention discloses Arcelin promoters capable of transcribing a heterologous nucleic acid sequence at high levels in plants. The promoters are particularly suited for use in soybean plants and plant cells. Methods of modifying, producing, and using the promoters are also disclosed. The invention further discloses compositions, transformed host cells, transgenic plants, and seeds containing the high-expression Arcelin promoters, and methods for preparing and using the same.
Type:
Grant
Filed:
December 17, 2001
Date of Patent:
August 9, 2005
Assignee:
Monsanto Technology LLC
Inventors:
Qi Wang, Patrice Dubois, Jihong Liang, Tim Oulmassov
Abstract: This invention provides promoters capable of transcribing heterologous nucleic acid sequences in seeds, and methods of modifying, producing, and using the same.
Abstract: The invention provides diacylglycerol acyltransferase (DAGAT) proteins, wherein said proteins are active in the formation of triacylglycerol from fatty acyl and diacylglycerol substrates. In one aspect, Mortierella ramanniana DAGAT proteins have been isolated and have molecular weights of between approximately 36 and 37 kDa as measured by SDS-PAGE. The invention also provides novel DAGAT polynucleotide and polypeptide sequences and to methods of producing such polypeptides using recombinant techniques. In addition, methods are provided for using such sequences to alter triacylglycerol levels in plants and to treat diseases associated with altered DAGAT activity or expression.
Type:
Grant
Filed:
April 15, 2002
Date of Patent:
November 23, 2004
Assignee:
Calgene LLC
Inventors:
Kathryn Dennis Lardizabal, Gregory A. Thompson, Deborah Hawkins